Pharmacokinetics of taxol and doxorubicin administered alone and in combination by continuous 72-hour infusion.
Berg
S L
SL
Pediatric Branch, National Cancer Institute, Bethesda, MD 20892.
Cowan
K H
KH
Balis
F M
FM
Fisherman
J S
JS
Denicoff
A M
AM
Hillig
M
M
Poplack
D G
DG
O'Shaughnessy
J A
JA
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000097:blood / Q000493:pharmacokinetics*; D001943:Breast Neoplasms / Q000097:blood / Q000188:drug therapy; D004317:Doxorubicin / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008875:Middle Aged; D017239:Paclitaxel / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*
D004317:Doxorubicin; D017239:Paclitaxel